Estazolam
- Generic Name
- Estazolam
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C16H11ClN4
- CAS Number
- 29975-16-4
- Unique Ingredient Identifier
- 36S3EQV54C
- Background
A benzodiazepine with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than diazepam or nitrazepam.
- Indication
For the short-term management of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.
- Associated Conditions
- Insomnia
- Associated Therapies
- -
"Chou's Tiaoshen" Acupoints for Short-term Insomnia.
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-01-19
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Target Recruit Count
- 96
- Registration Number
- NCT06212934
- Locations
- 🇨🇳
Beijing Hospital of Traditional Chinese Medicine, Beijing, Beijing, China
A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia Patients
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-08-11
- Last Posted Date
- 2011-10-06
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 42
- Registration Number
- NCT00956319
Randomised, Double-blind Study to Investigate the Safety and Efficacy of Brotizolam in Insomnia Outpatients.
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2017-12-28
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 253
- Registration Number
- NCT00347295
- Locations
- 🇨🇳
Beijing Hospital, Beijing, China
🇨🇳Peking Union Medical College Hospital, Beijing, China
🇨🇳Shanghai Mental Health Center, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath